Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $444.4M | $484.3M | $509.7M | $591.6M | $660.6M | $727.3M |
| Gross profit | $185.9M | $187.1M | $187.9M | $244.6M | $290.1M | $314.3M |
| Operating income | -$14.0M | -$118.8M | -$157.6M | -$107.7M | -$92.1M | -$115.9M |
| Net income | $4.2M | -$8.0M | -$144.0M | -$88.0M | -$79.0M | -$108.0M |
| Diluted EPS | — | — | — | — | — | — |
| Operating cash flow | $1.5M | -$26.7M | -$66.0M | -$2.0M | $7.0M | $5.2M |
| Free cash flow | -$27.6M | -$90.9M | -$96.9M | -$30.7M | -$34.0M | -$21.8M |
| Gross margin | 41.8% | 38.6% | 36.9% | 41.3% | 43.9% | 43.2% |
| Operating margin | -3.1% | -24.5% | -30.9% | -18.2% | -13.9% | -15.9% |
| Net margin | 0.9% | -1.7% | -28.3% | -14.9% | -12.0% | -14.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $164.5M | $167.8M | $172.0M | $168.0M | $181.3M | $187.8M | $190.2M | $186.7M |
| Gross profit | $72.5M | $74.9M | $77.3M | $73.2M | $77.3M | $80.4M | $83.3M | $80.9M |
| Operating income | -$21.9M | -$21.2M | -$18.4M | -$27.8M | -$47.6M | -$27.0M | -$13.4M | -$18.2M |
| Net income | -$18.6M | -$17.7M | -$15.6M | -$25.9M | -$45.1M | -$27.1M | -$9.9M | -$17.1M |
| Diluted EPS | — | — | — | — | — | — | — | — |
| Operating cash flow | $13.9M | $9.2M | $9.8M | -$25.3M | $20.3M | $8.9M | $1.3M | -$8.1M |
| Free cash flow | $814,000.00 | -$1.6M | -$1.8M | -$29.8M | $14.0M | $570,000.00 | -$6.5M | -$13.1M |
| Gross margin | 44.1% | 44.6% | 44.9% | 43.6% | 42.6% | 42.8% | 43.8% | 43.3% |
| Operating margin | -13.3% | -12.6% | -10.7% | -16.6% | -26.3% | -14.4% | -7.1% | -9.8% |
| Net margin | -11.3% | -10.5% | -9.1% | -15.4% | -24.9% | -14.4% | -5.2% | -9.2% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-15 | TETRAULT LYNN A. | Sale | 5,307 | $11.10 | $58,907.70 | filing |
| 2026-06-09 | TETRAULT LYNN A. | Sale | 5,307 | $11.29 | $59,916.03 | filing |
| 2026-06-01 | Kenny John P. | Option exercise | 5,893 | $0.00 | $0.00 | filing |
| 2026-06-01 | Williams Felicia | Option exercise | 23,077 | $0.00 | $0.00 | filing |
| 2026-06-01 | TETRAULT LYNN A. | Option exercise | 23,077 | $0.00 | $0.00 | filing |
| 2026-06-01 | Perez David Brian | Option exercise | 23,077 | $0.00 | $0.00 | filing |
| 2026-06-01 | Kelly Michael Aaron | Option exercise | 23,077 | $0.00 | $0.00 | filing |
| 2026-06-01 | KANOVSKY STEPHEN M | Option exercise | 23,077 | $0.00 | $0.00 | filing |
| 2026-06-01 | Gunn Neil | Option exercise | 23,077 | $0.00 | $0.00 | filing |
| 2026-06-01 | Green Marjorie C | Option exercise | 22,964 | $0.00 | $0.00 | filing |
| 2026-05-11 | Olivo Alicia C· EVP, GC & Business Development | Option exercise | 3,944 | $0.00 | $0.00 | filing |
| 2026-05-11 | Olivo Alicia C· EVP, GC & Business Development | Tax withholding | 2,559 | $0.00 | $0.00 | filing |
| 2026-05-11 | Stone Warren· Pres & Chief Operating Officer | Option exercise | 5,830 | $0.00 | $0.00 | filing |
| 2026-05-11 | Stone Warren· Pres & Chief Operating Officer | Tax withholding | 3,783 | $0.00 | $0.00 | filing |
| 2026-05-02 | Aunan Greg D· Chief Accounting Officer | Option exercise | 5,372 | $0.00 | $0.00 | filing |
| 2026-05-02 | Aunan Greg D· Chief Accounting Officer | Tax withholding | 1,309 | $0.00 | $0.00 | filing |
| 2026-05-02 | Stone Warren· Pres & Chief Operating Officer | Option exercise | 5,969 | $0.00 | $0.00 | filing |
| 2026-05-02 | Stone Warren· Pres & Chief Operating Officer | Tax withholding | 2,349 | $0.00 | $0.00 | filing |
| 2026-05-01 | Aunan Greg D· Chief Accounting Officer | Tax withholding | 937 | $0.00 | $0.00 | filing |
| 2026-05-01 | Olivo Alicia C· EVP, GC & Business Development | Tax withholding | 1,042 | $0.00 | $0.00 | filing |
| 2026-04-01 | Stone Warren· Pres & Chief Operating Officer | Option exercise | 17,562 | $0.00 | $0.00 | filing |
| 2026-04-01 | Stone Warren· Pres & Chief Operating Officer | Tax withholding | 6,911 | $0.00 | $0.00 | filing |
| 2026-04-01 | Zook Anthony P.· Chief Executive Officer | Option exercise | 140,498 | $0.00 | $0.00 | filing |
| 2026-04-01 | Zook Anthony P.· Chief Executive Officer | Tax withholding | 45,453 | $0.00 | $0.00 | filing |
| 2026-02-23 | Stone Warren· Pres & Chief Operating Officer | Option exercise | 8,443 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.